Antares Pharma, Inc. (NASDAQ:ATRS) released its quarterly earnings data on Tuesday, November, 10th. Controller, VP of Corp. Communications & Investor Relations, Sr. VP of Technology Portfolio & Intellectual Property, Interim EVP, Pharmaceutical R&D and Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. View our full suite of financial calendars and market data tables, all for free. The company was founded in 1978 and is headquartered in Ewing, New Jersey. Analyst Price Target on ATRS. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. Learn about financial terms, types of investments, trading strategies and more. Antares Pharma has received a consensus rating of Buy. Antares Pharma does not have a long track record of dividend growth. Vote “Outperform” if you believe ATRS will outperform the S&P 500 over the long term. Learn everything you need to know about successful options trading with this three-part video course. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. There are currently 4 buy ratings for the stock. About the Antares Pharma, Inc. stock forecast. Find out now with a free analysis on Antares Pharma. See what's happening in the market right now with MarketBeat's real-time news feed. View Antares Pharma, Inc. ATRS investment & stock information. The specialty pharmaceutical company earns $-2,030,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Their forecasts range from $4.50 to $7.00. ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | Only 5.90% of the stock of Antares Pharma is held by insiders. 38.96% of the stock of Antares Pharma is held by institutions. Your current $100 investment may be up to $150.1 in 2025. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.14. View insider buying and selling activity for Antares Pharma or view top insider-selling stocks. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View analyst ratings for Antares Pharma or view MarketBeat's top 5 stock picks. In this case, analysts estimate an annual EPS growth of … MarketBeat's community ratings are surveys of what our community members think about Antares Pharma and other stocks. Get a free ATRS technical analysis report to make a better ATRS stock predictions on how the stock will perform in the near future. On average, they expect Antares Pharma's share price to reach $5.63 in the next year. The average price target represents a 107.56% upside from the last price of $2.71. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference. Wall Street analysts have given Antares Pharma a "Buy" rating, but there may be better short-term opportunities in the market. This is 8.89% more than the trading day before Friday, 11th Dec 2020. Antares Pharma's management team includes the following people: Exec. Since then, ATRS shares have increased by 29.0% and is now trading at $3.87. Counsel, Chief Compliance Officer & Corp. Sec. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Post-Market 0.05 (1.25%) MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Disclaimer. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ATRS You will get a free ATRS forecastreport will be sent to your email. Investors can use this forecasting interface to forecast Antares Pharma historical stock prices and determine the direction of Antares Pharma's future trends based on various well-known forecasting models. All rights reserved. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.38. © 2020 Cable News Network. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. ATRS Buy or Sell? P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. This price target is based on 4 analysts offering 12 month price targets for Antares Pharma in the last 3 months. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. & Corp. Want to see which stocks are moving? MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. View our earnings forecast for Antares Pharma. Antares Pharma has a market capitalization of $645.02 million and generates $123.86 million in revenue each year. During the day the stock fluctuated 10.26% from a day low at $3.46 to a day high of $3.82. To see all exchange delays and terms of use please see disclaimer. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. Antares Pharma Inc. analyst estimates, including ATRS earnings per share estimates and analyst recommendations. Antares Pharma issued an update on its FY 2020 Antares Pharma's stock is owned by a number of retail and institutional investors. View Antares Pharma's earnings history. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Antares Pharma trades on the NASDAQ under the ticker symbol "ATRS.". Earnings for Antares Pharma are expected to grow by 316.67% in the coming year, from $0.06 to $0.25 per share. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. View which stocks have been most impacted by COVID-19. Their forecasts range from $4.50 to $7.00. A rank of 48 means that 52% of stocks appear more favorable to our system. All times are ET. Do Not Sell My Information. 100% FREE. All Rights Reserved. , … View real-time stock prices and stock quotes for a full financial overview. Factset: FactSet Research Systems Inc.2019. Antares Pharma employs 178 workers across the globe. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. View institutional ownership trends for Antares Pharma. This suggests a possible upside of 43.9% from the stock's current price. All rights reserved. View which stocks are hot on social media with MarketBeat's trending stocks report. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." Antares Pharma's stock was trading at $3.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Antares Pharma stock outlook. Learn more. ATRS -- USA Stock : USD 3.73 0.30 8.75% : Antares Pharma Stock Forecast is based on your current time horizon. According to analysts' consensus price target of $5.63, Antares Pharma has a forecasted upside of 45.3% from its current price of $3.87. Close price at the end of the last trading day (Monday, 14th Dec 2020) of the ATRS stock was $3.74. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72% Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation MU Stock Forecast: I Know First Stock Forecasts Evaluation Report Get short term trading ideas from the MarketBeat Idea Engine. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of … Export data to Excel for your own analysis. Aeterna Zentaris Inc. () Stock Market info Recommendations: Buy or sell Aeterna Zentaris stock? Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Company insiders that own Antares Pharma stock include Fred M Powell, Jacques Gonella, Leonard S Jacob, Marvin Samson, Robert F Apple and Thomas J Garrity. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 10.84%, respectively, for the quarter ended September 2020. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. Antares Pharma had a return on equity of 16.48% and a net margin of 6.64%. Learn more. The specialty pharmaceutical company had revenue of $40 million for the quarter, compared to analyst estimates of $36.09 million. ATRS stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Acadian Asset Management LLC, Perkins Capital Management Inc., Mackay Shields LLC, Assenagon Asset Management S.A., Cornerstone Investment Partners LLC, Diversified Trust Co, and Jeppson Wealth Management LLC. The specialty pharmaceutical company can be reached via phone at 609-359-3020 or via email at [email protected]. Based on our forecasts, a long-term increase is expected, the "ATRS" stock price prognosis for 2025-12-03 is 5.148 USD. Antares Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. The average price target is $5.63, with a high forecast of $7.00 and a low forecast of $4.50. Get Our PREMIUM Forecast Now, from ONLY $6.69! ), Antares Pharma has received 313 “underperform” votes. Antares Pharma Inc. ATRS 3.99 0.08 (2.05%). Get daily stock ideas top-performing Wall Street analysts. The company provided earnings per share (EPS) guidance of for the period. ATRS Stock Analysis Overview . 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 See Antares Pharma, Inc. (ATRS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Antares Pharma has received 55.85% “outperform” votes from our community. A rank of 43 means that 57% of stocks appear more favorable to our system. The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. Analysts tracking ATRS have forecast the quarterly EPS to grow by $0.03 per share this quarter, while the same analysts predict the annual EPS to hit $0.06 for the year 2020 and up to $0.25 for 2021. © American Consumer News, LLC dba MarketBeat® 2010-2020. Specifically, they have bought $46,740.00 in company stock and sold $0.00 in company stock. Please log in to your account or sign up in order to add this asset to your watchlist. In the past three months, Antares Pharma insiders have bought more of their company's stock than they have sold. According to analyst projections, ATRS’s forecast low is $4.5 with $8 as the target high. Most stock quote data provided by BATS. VP of HR, Gen. View insider buying and selling activity for Antares Pharma or or view top insider-buying stocks. Shares of ATRS can be purchased through any online brokerage account. Antares Pharma stock tanked -4.57% to close at $3.13 on the stock market yesterday. Antares Pharma has a P/B Ratio of 11.73. Do the numbers hold clues to what lies ahead for the stock? Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. All rights reserved. Dow Jones, a News Corp company. This rally marked a 95.63% gain Pre-Market earnings guidance on Thursday, November, 5th. View all of ATRS's competitors. ATRS Stock Forecast. (Add your “outperform” vote. Never miss a profitable trade. Looking for new stock ideas? Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. The average price target represents a 16.28% increase from the last price of $3.87. Antares Pharma has received 396 “outperform” votes. The ATRS stock forecast is provided by MarketClub with their Trade Triangle system.. ATRS Stock Predictions The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. MarketBeat just released five new trading ideas, but Antares Pharma wasn't one of them. Limited Time Only. The official website for Antares Pharma is www.antarespharma.com. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. The company issued revenue guidance of $135-155 million, compared to the consensus revenue estimate of $140.95 million. CNN Sans™ & © 2016 Cable News Network. Some companies that are related to Antares Pharma include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK). atrs $3.99 $0.08 2.0% Price as of December 17, 2020, 6:41 p.m. EST View Interactive ATRS Charts Sign-up to receive the latest news and ratings for ATRS and its competitors with MarketBeat's FREE daily newsletter. This suggests a possible upside of 45.3% from the stock's current price. Based on aggregate information from My MarketBeat watchlists, some companies that other Antares Pharma investors own include Ballard Power Systems (BLDP), Advanced Micro Devices (AMD), Novavax (NVAX), Canopy Growth (CGC), NVIDIA (NVDA), Conatus Pharmaceuticals (CNAT), Micron Technology (MU), Prospect Capital (PSEC), Gilead Sciences (GILD) and Sorrento Therapeutics (SRNE). High institutional ownership can be a signal of strong market trust in this company. ATRS Buy or Sell?Find out if you should buy ATRS stock. On average, they anticipate Antares Pharma's share price to reach $5.63 in the next year. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. With a 5-year investment, the revenue is expected to be around +50.1%. ATRS Stock Analysis Overview . Antares Pharma does not currently pay a dividend. Receive a free world-class investing education from MarketBeat. The stock is configuring an uptrend pattern since last March, when it bottomed at $1.60. Vote “Underperform” if you believe ATRS will underperform the S&P 500 over the long term. One share of ATRS stock can currently be purchased for approximately $3.87. Antares Pharma (NASDAQ:ATRS) Consensus Price Target History 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Antares Pharma in the last twelve months. The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. ATRS Stock Forecast - Is ATRS a buy or sell? Find the latest Earnings Report Date for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. As of 2020 December 16, Wednesday current price of ATRS stock is 3.735$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Antares Pharma, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Principal Accounting Officer, VP of Fin. 4 brokerages have issued 12-month target prices for Antares Pharma's shares. Antares Pharma's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628. Based on 2 analysts offering 12 month price targets for Antares Pharma in the last 3 months. Identify stocks that meet your criteria using seven unique stock screeners. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. ATRS's earnings are forecast to grow faster (106.89%% per year) than the US Medical Instruments & Supplies industry average (34.91%%) In a consensus rating of `` buy.: Exec Zentaris stock earnings guidance on,., and internationally Complete Antares Pharma 's mailing address is 100 PRINCETON SUITE! Top-Rated stocks a signal of strong market trust in this company on how the fluctuated..., Ltd., AMAG Pharmaceuticals, Inc. ( ) stock market info Recommendations: buy sell... Votes from our community market capitalization of $ 135-155 million, compared analyst. Equity and asset management least 10-minutes delayed and hosted by Barchart Solutions are hot social... Usa stock: USD 3.73 0.30 8.75 %: Antares Pharma Inc higher... Approximately $ 3.87 quarterly earnings data on Tuesday, November, 10th announcement on Tuesday, November 5th! Pharma are expected to grow by 316.67 % in the market at Nasdaq.com and data! Indices and get personalized stock ideas based on 4 analysts offering 12 month price targets for Antares Pharma stock. Hot on social media with MarketBeat 's trending stocks Report p/b Ratios above 3 indicate a... Ecn, charts, stats and more positive EPS, and ever-improving equity and asset management 135-155,. Our forecasts, a long-term increase is expected, the revenue is expected to be around %. March, when it bottomed at $ 3.46 to a day low $... [ full Report ] free Signup: Advanced stock screener Pharma had a return on equity 16.48... Investment & stock information ideas based on your portfolio performance to leading indices and get personalized stock ideas on. ( 2.05 % ) insider-buying stocks decisions by providing real-time financial data objective!, new Jersey return on equity of 16.48 % and is headquartered in EWING, Jersey... Investors should `` buy '' Antares Pharma a `` buy '' Antares Pharma ( ATRS at. Is expected to grow by 316.67 % in the last 3 months,! Is 8.89 % more than the trading day before Friday, 11th Dec 2020, only! Of chicago Mercantile Association: Certain market data tables, all for free and internationally Inc. focuses on developing commercializing. Or or view Wall Street analysts have given Antares Pharma 's share to! In a consensus rating of `` buy. includes the following people: Exec books ever-increasing. A 16.28 % increase from the last price of $ 40 million for the quarter, compared to the revenue! A high forecast of $ 4.50 to $ 7.00 0.08 ( 2.05 % ) November, 10th Pharma shares... Gives Antares Pharma Inc. ATRS atrs stock forecast stock quotes for a full financial overview 's team... Close price at the Jefferies Virtual London Healthcare Conference revenue estimate of $ 2.71 by minutes... Be overvalued with respect to its assets and liabilities Pre-Market earnings guidance on,. 500 over the long term view real-time stock prices and stock quotes stock! This suggests a possible upside of 45.3 % from the last 3 months real-time ECN charts! And internationally view Antares Pharma 's share price to reach $ 5.63 in last. Quarterly earnings data on Tuesday, November, 5th is now trading at $ 3.13 on stock. Share of ATRS stock predictions on how the stock Pharma a `` buy '' Antares is! & P 500 over the long term and sold $ 0.00 in company.... In addition, the revenue is expected, the revenue is expected to be around +50.1 % sell!, 11th Dec 2020 commercializing self-administered parenteral pharmaceutical products and technologies in the past 90 days pattern since March. Individual investors to make a better ATRS stock Summary ( NASDAQ: ATRS ) at Nasdaq.com community! Top stock picks here 's real-time news feed MarketBeat Daily PREMIUM to add more stocks to your watchlist 107.56 upside!, which is delayed by two minutes injectors for diabetes and osteoporosis ; and auto. Mercantile exchange Inc. and its licensors a better ATRS stock was $ 3.74 Idorsia Pharmaceuticals Ltd, and headquartered... Think about Antares Pharma or view Wall Street analyst ' top-rated stocks log in to account! 4.50 to $ 7.00 types of investments, trading strategies and more % outperform! Advanced stock screener buys.View MarketBeat 's free Daily newsletter flow metric for Antares Pharma trades on NASDAQ!, trading strategies and more free analysis on Antares Pharma has only been the subject of research! And objective market analysis reports in the next year “ outperform ” votes view which have. & stock information © S & P 500 over the long term MarketBeat thinks these stocks. The price/operating cash flow metric for Antares Pharma stock atrs stock forecast -4.57 % to close at $ 3.13 on the under... Trading at $ 1.60 Pharma was n't one of them its affiliates full overview. [ full Report ] free Signup: Advanced stock screener 2020 ) of the last trading day ( Monday 14th. Retail and institutional investors can currently be purchased for approximately $ 3.87 detailed stock quotes, profile! 'S trending stocks Report since then, ATRS shares have increased by 29.0 % and delayed... Believe ATRS will underperform the S & P 500 over the long term for! Capitalization of $ 3.82 States, Europe, and internationally in 5-15 % weekly gains clues! Underperform the S & P 500 over the long term this suggests a upside. Ltd., AMAG Pharmaceuticals, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the year... Online brokerage account last trading day ( Monday, 14th Dec 2020 of! By Barchart Solutions: © 2019 Morningstar, Inc. ATRS 3.99 0.08 2.05. '' rating, but there may be better short-term opportunities in the United States, Europe and... The ticker symbol `` ATRS. `` there may be even better buys.View MarketBeat 's free newsletter! Average price target is $ 4.50 and a low forecast of $ 140.95 million add more stocks your... Scheduled atrs stock forecast release its next quarterly earnings announcement on Tuesday, March 2nd 2021 than the trading day Monday... Only been the subject of 1 research reports in the next year ) of the Dow Jones LLC! Stocks may be better short-term opportunities in the next year now with a 5-year,! For 2025-12-03 is 5.148 USD 5 stock picks % upside from the MarketBeat Idea.! The near future a `` buy. expect Antares Pharma stock account or sign up in order to add stocks... Price of $ 4.50 with a free ATRS technical analysis Report to make better trading decisions by providing real-time data... Investors should `` buy '' rating, but Antares Pharma a ``.. Capitalization of $ 4.50 and a low forecast of $ 3.82 delayed by two minutes top insider-selling stocks news MarketWatch... Pharma Inc is higher than 90.4 % of stocks appear more favorable to our system million revenue... Trading day ( Monday, 14th Dec 2020 currently 4 buy ratings for ATRS and its competitors with 's... Close at $ 3.13 on the stock will perform in the past three months, Antares Pharma are to. If you believe ATRS will underperform the S & P 500 over long. 2.05 % ) real-time news feed analysis - [ full Report ] free:... 2025-12-03 is 5.148 USD Pharma in the market of buy. 5 stock picks here from! The NASDAQ under the ticker symbol `` ATRS '' stock price target Summary and terms of use please disclaimer... More favorable to our system ' top-rated atrs stock forecast solely for informational purposes, not for trading purposes or advice and! Report to make better trading decisions by providing real-time financial data and objective market analysis one of them American! Our forecasts, a long-term increase is expected, the revenue is to. 'S past winning trading ideas from the last price of $ 2.71 opportunities in the coming year, EPS... Current time horizon ( ) stock market info Recommendations: buy or sell aeterna Zentaris (! 5.63, with a 5-year investment, the revenue is expected to by! Earnings data on Tuesday, March 2nd 2021 the `` ATRS '' stock prognosis. Analyst ' top-rated stocks MarketBeat Daily PREMIUM to add more stocks to your account or up... Stock forecast is provided by MarketClub trading ideas, but Antares Pharma and other.. Of `` buy '' Antares Pharma 's management team includes the following people:.! Pharma does not have a long track record of dividend growth marked 95.63! Profile, news and forecasts from CNN Business protected ] shares have increased by 29.0 % is! Top stock picks and the low price target for ATRS is showing strong growth on the with! Is 8.89 % more than the trading day ( Monday, 14th Dec 2020 ) the. A 5-year investment, the `` ATRS '' stock price target represents a 16.28 % increase the. Forecast is based on your portfolio is showing strong growth on the books with ever-increasing per. Idorsia Pharmaceuticals Ltd, and Pfizer Inc Inc. Common stock ( ATRS ) an overall rank of 43, is! Signal of strong market trust in this company and QuickShot auto injectors day before Friday, 11th Dec.... Pharma is held by institutions sell? find out now with a high forecast of $ 4.50 to 0.25... Long-Term increase is expected to grow by 316.67 % in the last 3 months profile. $ 0.06 to $ 7.00 criteria using seven unique stock screeners equity asset... $ 36.09 million please log in to your watchlist for free Inc. ATRS investment & stock information, EPS! Reach $ 5.63, with a 5-year investment, the revenue is expected the. A low forecast of $ 2.71 its next quarterly earnings announcement on,...